LSNE Appoints New COO - - BioPharm International

ADVERTISEMENT

LSNE Appoints New COO



Untitled Document

Lyophilization Services of New England (LSNE), a New Hampshire based contract-manufacturing organization, has appointed Shawn Cain as COO, a new position within the company. Cain joined LSNE in 2012 as vice- president of sterile manufacturing. In his new role, Cain will be responsible for overseeing day-to-day operations and ensuring companywide alignment with the corporate goals. Cain will report to Matthew Halvorsen, president and CEO of LSNE. Cain's 28-year career includes experience in the pharmaceutical, biotech, and medical device industries. Cain has held management positions within operations at Organogenesis, Formatech, Arbios Systems, and Becton Dickinson.

Source: LSNE

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

New Tax Rules May Deter Future Pharma M&A
October 1, 2014
NIH Seeks to Improve Vaccine Response with New Adjuvants
September 30, 2014
New Report Details Players and Pipelines in the Biosimilar Space
September 30, 2014
Baxter International Plans to Open R&D Center for Baxalta
September 30, 2014
FDA Releases First-Ever Purple Book for Biosimilar Characterization
September 26, 2014
Author Guidelines

Click here